Immunology And Cancer Flashcards
AKA FK-506. Inhibits secretion of IL-2. Side effects include Nephrotoxicity, peripheral neuropathy, pleural effusion, hyperglycemia, and hypertension. What is the name of this drug?
Tacrolimus
This drug inhibits calcineurin which prevents production of IL-2 and its receptor. It also binds to cyclophilins.
Cyclosporine
This drug is AKA Rapamycin. It recognizes and sees IL-2. It limits T-Cell proliferation. Side effects include hyperlipidemia, thrombocytopenia, and leukopenia.
Sirolimus
**Pay close attention that this drug causes hyperlipidemia because it doesn’t follow the same pattern as the other 2 side effects.
This drug acts as an antibody against IL-2 receptor. Clinical use of this drug is for Px that underwent a kidney transplant. What is the name of this drug?
Daclizumab
This drug is the Antimetabolite precursor of 6-mercaptopurine that interferes with metabolism and synthesis of nucleic acids. Clinical use includes kidney transplants, autoimmune disorders (glomerulonephritis & hemolytic anemia). SE: Bone marrow suppression, active metabolite-mercaptopurine is metabolized by Xanthine oxidase, and toxic effects are increased on Allopurinol. What is the name of this drug?
Azathioprine
Monoclonal AB that binds to CD3 (epsilon chain) on the surface of T-Cells –> Blocks T-Cell transduction. Clinical use: immunosupression after kidney transplantation. SE: cytokine release syndrome, and hypersensitivity.
Muromonab
Like: moron, 3 stooges, for CD3.
Target: erb-B2:protoonco gene loc on ch17.
Clinical use: Her-2 over expressing breast cancer.
What is the name of this drug?
Trastuzumab/Herceptin
Don’t trust-her!
Target CD20. Clinical use: B-cell non-Hodgkin’s lymphoma. Name this drug:
Rituximab
Target is TNF-alpha (aka-cachexia). Clinical use: Crohn’s disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis. Name the drug:
Infliximab
Target: TNF-alpha. Clinical use: Crohn’s disease, rheumatic arthritis, psoriatic arthritis. Name the 2 drugs that do the same thing:
Adalimumab and Etanercept
Target: Digoxin or digoxin poisoning. It inhibits Na/K ATPase. This medication causes yellow vision and blurring. It incr. ST, decr. QT interval, and creates a T-wave inversion.
Digoxin immune fab.
Target: Glycoprotein IIb/IIIa. Clinical use: prevents cardiac ischemia in unstable angina, percutaneous coronary intervention patients, current myocardial infarction patients.
Abciximab
Target: IgE
Clinical use: treatment option for severe asthma.
Omalizumab
Target: Inosine mono phosphate dehydrogenase. Prevents production of the Nucleoside guanine. Leads to rapid arrest of B/T cell production.
Clinical use: transplants, Lupus glomerulonephritis
Mycophenolate
Target: TNF-alpha. Clinical use: immunosuppression: SLE, organ transplants, anti-angiogenic. Do NOT give while pregnant. SE include: Phocomelia (fetal development problems)- underdeveloped/malformed limbs and bones. Encephalocele, hydrocephalus, heart and kidney malformations, short stature, and bicornate uterus.
Thalidomide
This drug is an interleukin-2 recombinant cytokine. Clinical use: renal cell carcinoma, metastatic melanoma.
Aldesleukin
Clinical use: Anemias- in renal failure, especially due to EPO not being produced.
Epoetin recombinant cytokine
Erythropoietin
Granulocyte Colony-Stimulating Factor Recombinant Cytokine. IL-3. Clinical use: aid bone marrow recovery. Name this drug:
Filgrastim
Granulocyte- Macrophage Colony Stimulating Factor Recombinant Cytokine. IL-3. Clinical use: aid bone marrow recovery.
Sargramostim
Recombinant cytokine. Clinical use for hepatitis B&C, Kaposi’s Sarcoma, Leukemias, malignant melanoma.
Alpha-interferon